End-of-day quote
Other stock markets
|
||
- GBX | - |
2016 | GlaxoSmithKline : Vectura to buy SkyePharma for 441 million pounds as UK biotech consolidates | RE |
2016 | Skyepharma : estimates full-year revenue ahead of its expectations | RE |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 105,912,259 | 0 | 0 | - |
Company contact information
Sector
1st Jan change | Capi. | |
---|---|---|
+25.83% | 661B | |
+27.00% | 566B | |
-6.76% | 352B | |
+20.34% | 332B | |
+3.00% | 283B | |
+13.09% | 231B | |
+5.46% | 200B | |
-9.61% | 195B | |
-6.26% | 145B |
- Stock Market
- Equities
- Stock
- Company SkyePharma PLC